[4-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl-carbamoyl)-2-oxo-2H-pyridin-1-yl]-acetic acid ethyl ester | 533932-04-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: [4-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl-carbamoyl)-2-oxo-2H-pyridin-1-yl]-acetic acid ethyl ester
• 英文别名: [4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-2-oxo-2H-pyridin-1-yl]-acetic Acid Ethyl Ester；ethyl 2-[4-[(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)carbamoyl]-2-oxopyridin-1-yl]acetate
• CAS: 533932-04-6
• 化学式: C₂₂H₂₄N₄O₆S
• 分子量: 472.522
• InChiKey: NHENNNNIWFADHU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  33
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  139
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  2-methoxy-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-isonicotinamide 、 溴乙酸乙酯 在 sodium iodide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 [4-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl-carbamoyl)-2-oxo-2H-pyridin-1-yl]-acetic acid ethyl ester
  参考文献：
  名称：

  Pyridone substituted benzothiazole derivatives

  摘要：

  本发明涉及下式化合物，其中R如下所定义。式I的化合物具有良好的与A2A受体的亲和力，因此它们可以用于控制或预防基于腺苷系统调节的疾病，如阿尔茨海默病、帕金森病、亨廷顿病、神经保护、精神分裂症、焦虑、疼痛、呼吸障碍、抑郁症、药物成瘾（如安非他命、可卡因、阿片类、乙醇、尼古丁、大麻素）以及哮喘、过敏反应、低氧、缺血、癫痫和物质滥用等疾病。此外，本发明的化合物可以用作镇静剂、肌肉松弛剂、抗精神病药、抗癫痫药、抗惊厥药和心脏保护剂，用于治疗冠状动脉疾病和心力衰竭等疾病。

  公开号：

  US06599901B1

文献信息

• BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1448196B1

  公开（公告）日：2005-10-12
• US6599901B1
  申请人：——

  公开号：US6599901B1

  公开（公告）日：2003-07-29
• [EN] BENZOTHIAZOLE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS<br/>[FR] DERIVES BENZOTHIAZOLE CONVENANT COMME LIGANDS DU RECEPTEUR DE L'ADENOSINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2003043634A1

  公开（公告）日：2003-05-30

  The present invention relates to compounds of the general formula (I): wherein R is phenyl, pyridin-2-yl, -C(O)-O-lower alkyl, -C(O)-lower alkyl, -C(O)-morpholinyl, -C(O)-NR'2,-(CH2)N-NR'2or -(CH2)N-O-lower alkyl and R' may be hydrogen or lower alkyl; and to pharmaceutically acceptable acid addition salts thereof. The compounds disclosed in this application have a good affinity to the A2A receptor and therefore they may be used in the control or prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, drug addiction, such as amphetamine, cocaine, opioids, ethanol, nicotine, cannabinoids, or against asthma, allergic responses, hypoxia, ischaemia, seizure and substance abuse. Furthermore, compounds of the present invention may be useful as sedatives, muscle relaxants, antipsychotics, antiepileptics, anticonvulsants and cardiaprotective agents for disorders such as coronary artery disease and heart failure.
• Pyridone substituted benzothiazole derivatives
  申请人：Hoffman-La Roche Inc.

  公开号：US06599901B1

  公开（公告）日：2003-07-29

  The present invention relates to compounds of the formula wherein R is as defined herewithin. The compounds of formula I have a good affinity to the A2A receptor and therefore they may be used in the control or prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, drug addiction, such as amphetamine, cocaine, opioids, ethanol, nicotine, cannabinoids, or against asthma, allergic responses, hypoxia, ischaemia, seizure and substance abuse. Furthermore, compounds of the present invention may be useful as sedatives, muscle relaxants, antipsychotics, antiepileptics, aniticonvulsants and cardiaprotective agents for disorders such as coronary artery disease and heart failure.

  本发明涉及公式I中R定义的化合物。公式I中的化合物具有良好的A2A受体亲和力，因此它们可用于调节腺苷系统的疾病的控制或预防，如阿尔茨海默病、帕金森病、亨廷顿病、神经保护、精神分裂症、焦虑症、疼痛、呼吸功能障碍、抑郁症、药物成瘾，如苯丙胺、可卡因、阿片类、乙醇、尼古丁、大麻素，或用于哮喘、过敏反应、低氧、缺血、癫痫和物质滥用等疾病。此外，本发明的化合物可用作镇静剂、肌肉松弛剂、抗精神病药、抗癫痫药、抗惊厥药和心脏保护剂，用于冠状动脉疾病和心力衰竭等疾病。